首页> 美国卫生研究院文献>Malaria Journal >Diversity pattern of Duffy binding protein sequence among Duffy-negatives and Duffy-positives in Sudan
【2h】

Diversity pattern of Duffy binding protein sequence among Duffy-negatives and Duffy-positives in Sudan

机译:苏丹达菲阴性和达菲阳性患者中达菲结合蛋白序列的多样性模式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundVivax malaria is a leading public health concern worldwide. Due to the high prevalence of Duffy-negative blood group population, Plasmodium vivax in Africa historically is less attributable and remains a neglected disease. The interaction between Duffy binding protein and its cognate receptor, Duffy antigen receptor for chemokine plays a key role in the invasion of red blood cells and serves as a novel vaccine candidate against P. vivax. However, the polymorphic nature of P. vivax Duffy binding protein (DBP), particularly N-terminal cysteine-rich region (PvDBPII), represents a major obstacle for the successful design of a DBP-based vaccine to enable global protection. In this study, the level of pvdbpII sequence variations, Duffy blood group genotypes, number of haplotypes circulating, and the natural selection at pvdbpII in Sudan isolates were analysed and the implication in terms of DBP-based vaccine design was discussed.
机译:背景Vivax疟疾是全球主要的公共卫生问题。由于达菲阴性血型人群的高患病率,非洲间日疟原虫的病因较少,仍然是被忽视的疾病。 Duffy结合蛋白与其同源受体Duffy趋化因子抗原受体之间的相互作用在红细胞入侵中起关键作用,并作为抗间日疟原虫的新型候选疫苗。然而,间日疟原虫达菲结合蛋白(DBP),尤其是N端富含半胱氨酸的区域(PvDBPII)的多态性,代表了成功设计基于DBP的疫苗以实现全面保护的主要障碍。在这项研究中,分析了苏丹分离株中pvdbpII序列变异的水平,达菲血型基因型,循环单倍型的数目以及pvdbpII的​​自然选择,并讨论了基于DBP的疫苗设计的意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号